Unum Group UNM
Composite 43/100; the shares have moved about 24% annualised. Names that move more contribute more risk for the same amount invested, and our composite reflects how strong the evidence for this one is right now.
Growth ranks 16/100 — a strong mark against it.
Momentum ranks 78/100 — a strong point in its favour. Income ranks 61/100 — a slight point in its favour.
Growth ranks 16/100 — a strong mark against it. Quality ranks 34/100 — a moderate mark against it. Balance-sheet strength ranks 36/100 — a moderate mark against it.
What the company does Unum Group provides group and voluntary disability, life, accident, and critical-illness products to employers in the US, UK, and Poland. Its segments include Unum US, Unum International, Colonial Life, and Closed Block, with a sales force of field personnel, brokers, and independent agents.
Key financials Unum’s trailing P/E is 18.71 (forward 8.22), P/B 1.26, and net margin 5.9%. ROE is 7.1%, ROA 1.2%, and ROCE 1.9%. Revenue grew 8.5% and EPS 33.0%, with a dividend yield of 1.6% and payout ratio 42.7%.
Stock health Sideravia scores Unum’s quality at 29.8 and growth at 32.4, but valuation at 77.1 and momentum at 66.6. The stock is down 6.37% from its 52-week high and has an RSI(14) of 48.20.
Price vs fair value The stock trades at a discount to both our fair-value estimate and the analyst target: - Price is at a 27.40% discount to our fair-value estimate of 110.53 (StockStory). - Price is at a 17.46% discount to the 12-month target of 101.92 (analyst count 13.0) (StockStory). - Simply Wall St notes Unum’s 292% five-year run and questions earnings softness amid buybacks and LTC reinsurance.
Looking forward Forward P/E of 8.22 and PEG of 0.06 suggest potential valuation appeal, though quality and growth metrics remain weak. Q2 earnings beat estimates on premium growth, but segment trends and rate actions temper near-term outlook (Zacks, StockStory).
This is not investment advice. Sideravia provides automated, data-driven analysis for information and education only. Nothing on this page is a personal recommendation or an invitation to buy or sell any security, and it does not consider your objectives or financial situation. Assessments are generated by rules applied uniformly to every covered stock — how our scores work.
Data as of 2026-09-04, compiled from third-party sources; errors and delays are possible and figures are not warranted. Investing puts your capital at risk; past performance does not predict future results. We publish our full track record, including the calls that lost, and our conflicts of interest.